Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals:: results from both cross-sectional and interventional study

被引:84
作者
Gannage-Yared, Marie-Helene [1 ]
Yaghi, Cesar [2 ]
Habre, Bassein [1 ]
Khalife, Simon [3 ]
Noun, Roger [4 ]
Germanos-Haddad, Myrna [5 ]
Trak-Smayra, Viviane [6 ]
机构
[1] St Josephs Univ, Dept Endocrinol, Beirut, Lebanon
[2] St Josephs Univ, Dept Gastroenterol, Beirut, Lebanon
[3] St Josephs Univ, Dept Biostat, Beirut, Lebanon
[4] St Josephs Univ, Immunol Lab, Beirut, Lebanon
[5] St Josephs Univ, Dept Gen Surg, Beirut, Lebanon
[6] St Josephs Univ, Dept Pathol, Beirut, Lebanon
关键词
D O I
10.1530/EJE-07-0797
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: We analyzed the relation of osteoprotegerin (OPG) with insulin sensitivity, lipid profile, serum glutamic pyruvic transaminase (SGPT), adipocytokines, and C-reactive protein (CRP) in obese and non-obese subjects. Methods: In the study, 170 subjects (106 obese and 64 non-obese, sex ratio female/male=2.03) were included. Thirty-two obese subjects were reevaluated 6 months after the weight loss induced by bariatric surgery. Results: OPG did not differ between obese and non-obese subjects (respective mean values 5.17 and 4.96 pmol/l) or according to gender, but was positively correlated with age (P < 0.0001 for both groups). OPG was statistically higher in 18 obese diabetic subjects compared with non-diabetics (P=0.03). After adjustment for age, no significant correlation was found between OPG and body mass index (BMI), waist, systolic and diastolic blood pressure, cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol, leptin, and adiponectin in both the obese and non-obese subjects. However, OPG was positively correlated with homeostasis model assessment (HOMA) index and SGPT levels in obese subjects at baseline (r=0.295, r=0.20, P < 0.05) and after adjustment for age (r=0.28, r=0.20, P < 0.05). OPG was also significantly correlated with CRP; this correlation persisted after adjustment for age in obese subjects (r=0.30, P < 0.01). In a multivariate analysis in the obese group, HOMA index and CRP were independent predictors of OPG while SGPT was not. Six months post-surgery, OPG did not change, despite a significant reduction in glucose, SGPT, cholesterol, triglycerides, CRP, and leptin values (P=0.02, P=0.006, P=0.007, P < 0.001, P < 0.001, P < 0.001 respectively) and a significant increase in adiponectin and HDL values (P < 0.001 for both variables). Conclusion: Our results show that in obese subjects, OPG is not related to BMI. However, we describe new relationships between OPG and both HOMA index and CRP.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 34 条
[1]
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects [J].
Anand, DV ;
Lahiri, A ;
Lim, E ;
Hopkins, D ;
Corder, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) :1850-1857
[2]
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].
Browner, WS ;
Lui, LY ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637
[3]
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[4]
Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis [J].
Collin-Osdoby, P ;
Rothe, L ;
Anderson, F ;
Nelson, M ;
Maloney, W ;
Osdoby, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20659-20672
[5]
Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population [J].
Gannage-Yared, Marie-Helene ;
Fares, Florence ;
Semaan, Michelle ;
Khalife, Simon ;
Jambart, Selim .
CLINICAL ENDOCRINOLOGY, 2006, 64 (06) :652-658
[6]
Checklist comparison and dominance patterns of the fish fauna at Taim Wetland, South Brazil [J].
Garcia, Alexandre M. ;
Bemvenuti, Marlise A. ;
Vieira, Joao P. ;
Marques, David M. L. Motta ;
Burns, Marcelo D. M. ;
Moresco, Alex ;
Condini, Mario Vinicius L. .
NEOTROPICAL ICHTHYOLOGY, 2006, 4 (02) :261-268
[7]
Hepatic osteodystrophy: Does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role? [J].
Gaudio, A ;
Lasco, A ;
Morabito, N ;
Atteritano, M ;
Vergara, C ;
Catalano, A ;
Fries, W ;
Trifiletti, A ;
Frisina, N .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (08) :677-682
[8]
Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells [J].
Hofbauer, LC ;
Shui, CX ;
Riggs, BL ;
Dunstan, CR ;
Spelsberg, TC ;
O'Brien, T ;
Khosla, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) :334-339
[9]
The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases [J].
Hofbauer, LC ;
Heufelder, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2355-2363
[10]
The influence of weight loss on serum osteoprotegerin concentration in obese Perimenopausal women [J].
Holecki, Michal ;
Zahorska-Markiewicz, Barbara ;
Janowska, Joanna ;
Nieszporek, Teresa ;
Wojaczynska-Stanek, Katarzyna ;
Zak-Golab, Agnieszka ;
Wiecek, Andrzej .
OBESITY, 2007, 15 (08) :1925-1929